Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (5240)	5/31/2019 8:47:39 AM
From: richardred	Respond to of 7254

RE-ENZ speculation Harbert Management Corp Acquires 63,677 Shares of Enzo Biochem, Inc. (ENZ) Stock Posted by Jim Brewer on May 31st, 2019 Enzo Biochem, Inc. (NYSE:ENZ) major shareholder Harbert Management Corp bought 63,677 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was purchased at an average price of $3.09 per share, with a total value of $196,761.93. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC. NYSE:ENZ traded up $0.01 during mid-day trading on Thursday, reaching $3.09. The stock had a trading volume of 61,400 shares, compared to its average volume of 189,872. Enzo Biochem, Inc. has a one year low of $2.32 and a one year high of $6.76. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.38 and a current ratio of 3.83. wkrb13.com